To the best of our knowledge, this is the first systematic review and meta-analysis to evaluate the association between serum visfatin levels and NAFLD, the presence and severity of hepatic steatosis, as well as liver fibrosis, lobar inflammation, NASH, and gender differences. This evidence concerns the gene NAMPT and metabolic dysfunction-associated steatohepatitis.